SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 21, 2005 --------------- Strategic Diagnostics Inc. ----------------------------------------------------- (Exact Name of Registrant Specified in Charter) Delaware 000-68440 56-1581761 - --------------- --------------------- ---------- (State or Other (Commission File (I.R.S. Employer Jurisdiction of Number) Identification No.) Incorporation) 111 Pencader Drive Newark, DE 19702 - ---------------------------------------- ---------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (302) 456-6789 -------------- ITEM 7.01. REGULATION FD DISCLOSURE. On April 21, 2005, Strategic Diagnostics Inc. issued a press release announcing its entry into a distribution agreement with US Biosystems, a leading provider of environmental testing and data management services. A copy of that press release is being furnished as Exhibit 99.1 to this report. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STRATEGIC DIAGNOSTICS INC. By: /s/ Anthony J. Simonetta --------------------------------- Anthony J. Simonetta Chief Financial Officer Dated: April 22, 2005